Monitoring Response to Radiotherapy in Human Squamous Cell Cancer Bearing Nude Mice: Comparison of 2′-deoxy-2′-[18F]fluoro-d-glucose (FDG) and 3′-[18F]fluoro-3′-deoxythymidine (FLT)
Open Access
- 21 July 2007
- journal article
- research article
- Published by Springer Nature in Molecular Imaging & Biology
- Vol. 9 (6) , 340-347
- https://doi.org/10.1007/s11307-007-0104-5
Abstract
The uptake of 3′-[18F]fluoro-3′-deoxythymidine (FLT), a proliferation marker, was measured before and during fractionated radiotherapy to evaluate the potential of FLT-positron emission tomography (PET) imaging as an indicator of tumor response compared to 2′-deoxy-2′-[18F]fluoro-d-glucose (FDG).Keywords
This publication has 41 references indexed in Scilit:
- Metabolism of 3′-deoxy-3′-[F-18]fluorothymidine in proliferating A549 cells: Validations for positron emission tomographyNuclear Medicine and Biology, 2004
- The uptake of 3?-deoxy-3?-[18F]fluorothymidine into L5178Y tumours in vivo is dependent on thymidine kinase 1 protein levelsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2004
- Molecular pathology of head‐and‐neck cancerInternational Journal of Cancer, 2004
- Biologic Correlates of 18Fluorodeoxyglucose Uptake in Human Breast Cancer Measured by Positron Emission TomographyJournal of Clinical Oncology, 2002
- Radiation-induced changes in nucleotide metabolism of two colon cancer cell lines with different radiosensitivitiesInternational Journal of Radiation Biology, 1999
- Imaging proliferation in vivo with [F-18]FLT and positron emission tomographyNature Medicine, 1998
- Early Prediction of Treatment Outcome in Head and Neck Cancer with 2-18FDG PETActa Oncologica, 1997
- Mammalian deoxyribonucleoside kinasesPharmacology & Therapeutics, 1995
- Human ovarian cancer xenografts in nude mice: Characterization and analysis of antigen expressionInternational Journal of Cancer, 1991
- Determination of subcutaneous tumor size in athymic (nude) miceCancer Chemotherapy and Pharmacology, 1989